microRNAs are single-stranded, non-coding RNAs that regulate gene expression. The microRNA-16 family has been reported to be involved in cell-cycle regulation, which could also downregulate expression of multiple pro-proliferation genes. The present results demonstrated that miR-16 expression in HeLa cells increased when the cells were arrested during S-phase under methyl methanesulfate (MMS) treatment. This further resulted in downregulation of a target protein CDC25A, whereas miR-16 expression did not increase when HeLa cells were arrested during the MMS-treated G 0 /G 1 or G 2 /M phase. Furthermore, when HeLa cells were arrested during S-phase with hydroxyurea treatment, miR-16 expression did not increase. These results suggest that expression levels of microRNAs in mammalian cells are delicately regulated under variable cellular conditions. microRNA, cell cycle, DNA damage, methyl methanesulfate, HeLa cells
microRNAs (miRNAs) are single-stranded, non-coding RNAs, ~21 to 23-nucleotides in length, which are generated from larger precursors transcribed from non-coding genes [1] . Results show that miRNAs, as gene regulatory molecules, are involved in many physiological and pathological processes, such as proliferation, differentiation, and tumorigenesis [2] . In addition, the function of miRNAs in mammalian cells has been shown to predominantly decrease target mRNA levels [3] . Furthermore, miRNAs could have a tuning role in regulating gene expression; and the unique features of miRNA-mediated gene regulation have recently been characterized, including the rapid turning off of protein production, as well as reversibly and compartmentalized regulating gene expression [4] . These properties could allow miRNAs to rapidly respond to subtle environmental changes or intracellular stresses.
The miRNA-16 (miR-16) family is involved in cell-cycle *Corresponding author (email: wujr@sibs.ac.cn) regulation, which down-regulates expression of multiple proproliferation factors, such as CDK6 and Cyclin D1, resulting in G 0 /G 1 arrest [5, 6] . Interestingly, cell-cycle inhibition of miR-16 is cell-type dependent, and over-expression of miR-16 significantly increases G 0 /G 1 population in HCT116, A549, and MCF7 cells, but does not induce a measurable cell-cycle change in HeLa cells [5] . In addition, repression of Cyclin D1 by miR-16 results in G 0 /G 1 arrest of A549 cells, whereas the same effect leads to no G 0 /G 1 accumulation in HepG2 or MEG-01 cells [6] . It is possible that miR-16 targets act in concert, rather than individually, and differential effects are due to various cellular contexts. The present study analyzed expressional change of miR-16 levels in HeLa cells at different stages of cell cycle with different DNA-damage reagents. Results showed that miR-16 expression in HeLa cells was upregulated only when cells were arrested in S-phase under methyl methanesulfate (MMS) treatment.
Materials and methods

Materials
Hydroxyurea (HU), methyl methanesulfate (MMS), RNase A and propidium iodide (PI) were purchased from SigmaAldrich. Fetal bovine serum (FBS) and DMEM medium were purchased from Invitrogen Life Technologies. HeLa cells were obtained from American Type Culture Collection. CDC25A antibody was purchased from Cell Signaling Technology; β-actin antibodies were purchased from SantaCruz; anti-mouse IgG, anti-rabbit IgG and ECL kit were purchased from Amersham.
Cell culture and cell synchrony
HeLa cells were cultured in Dulbecco's-modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS) and 100 U/mL penicillin/streptomycin (Gibco) at 37°C. For synchronization experiments, exponentially growing HeLa cells were initially treated with 2 mmol/L hydroxyurea (HU) for 12 h, were released in a HU-free medium for 10 h, and then subjected to a second round of HU treatment for 12 h. Ultimately, highly synchronized cells were obtained at the G 1 /S boundary. For drug-treatment experiments, HeLa cells from the HU double-block were released and subjected to 0.8-mmol/L MMS treatment at the indicated time points.
Flow cytometric analysis
HeLa cells were harvested and fixed with 70% ethanol at 4°C. The fixed cells were resuspended in a PBS solution containing 500 μg/mL RNase A and incubated at 37°C for 1 h. Cellular DNA was stained with 30 μg/mL PI. Flow cytometry analysis was performed with a FACScalibur flow cytometer (BD FACScan).
Western blot analysis
HeLa cells were lysed in 1× SDS buffer (50 mmol/L Tris, 2% SDS, 0.1% bromophenol blue, 10% glycerol, 100 mmol/L DTT, pH 6.8) and boiled for 10 min. Whole cell lysates were subjected to 10% SDS-PAGE gel electrophoresis, and the proteins were then transferred to PVDF membranes using a semi-dry transfer system (Bio-Rad). After blocking with 10% non-fat milk in TBS-T for 1 h, the membrane was probed with primary monoclonal antibody specific to CDC25A (1 : 1000) for 90 min, or β-actin (1 : 2000) for 90 min, which served as an internal control. Membranes were further incubated with anti-mouse IgG or anti-rabbit IgG and detected using an ECL kit.
RNA extraction and qRT-PCR
Total RNA from cultured HeLa cells was extracted using Trizol Reagent (Invitrogen) according to manufacture protocols. Reverse transcription was performed using 200 ng total RNA with 0.2 μL MMLV Reverse Transcriptase (Takara) according to the manufacture protocol. qRT-PCR was performed as described using a real-time PCR Quantitation Kit (GenePharma). PCR reactions were conducted using an ABI3000 real-time PCR machine at 95°C for 3 min, followed by 40 cycles of 95°C for 12 s and 62°C for 50 s. Each sample was analyzed in triplicate, and U6 snRNA was used for normalization. The abundance of miR-16 in HeLa cells, which was relative to the average expression, was calculated using RQ=2 −ΔΔC T , where
experimental − (C T miRNA −C T U6 RNA ) control.
Anti-miR-16 transfection
Equal numbers of HeLa cells (3 × 10 4 ) were seeded into 6-well culture plates and cultured for 1 d, followed by incubation with 2 mmol/L HU for 12 h. The HU-treated cells were then incubated with fresh medium and transiently transfected with synthesized anti-miR-16 oligonucleotides (miR-16 inhibitor) at a final concentration of 100, 200 and 400 nmol/L using Llipofectamine 2000 reagent (Invitrogen), respectively, for 6 h. Synthesized random oligonucleotides served as the miR-16 negative control. Following transfection, the transfectants were re-cultured with fresh medium for an additional 4 h, treated with 2 mmol/L HU for 12 h, and subjected to further analysis.
Results and discussion
S-phase dependent miR-16 upregulation in MMStreated HeLa cells
We recently reported that cell-cycle progression of HeLa cells could be arrested with a DNA damaging alkylating agent MMS, showing that cells at different phases exhibit different sensitivity to MMS treatment [7] . The same observation was shown in Figure 1 (Figure 1(d) ). miR-16 expression in different phases of untreated HeLa cells (Figure 1(a) ) was also measured and served as the control, of which expression levels at different phases did not reveal significant variation (Figure 1(b) ). In summary, these results suggest that miR-16 upregulation in MMS-treated HeLa cells is S-phase-dependent. 
miR-16 upregulation results in decreased CDC25A expression
Because CDC25A, an cell-cycle regulator in S phase [8] , was reported to be negatively regulated by miR-16 [5, 9] , expression levels of CDC25A protein in S-phase HeLa cells were measured with or without MMS treatment by Western blot analysis. Results revealed significantly downregulated CDC25A protein in S-phase-arrested HeLa cells treated with MMS (Figure 2(a) and (b) ), suggesting that upregulation of miR-16 expression in S-phase-arrested cells resulted in downregulated CDC25A expression. This was in agreement with a previous report that downregulated CDC25A transcription levels were solely dependent on UV-induced miR-16 in a miR-16 knockdown experiment (see Figure 5D of ref. [9] ).
The regulatory relationship between miR-16 and CDC25A was further confirmed using synthesized antimiR-16 oligonucleotides (Materials and methods). Results showed that inhibition of miR-16 upregulation by the miR-16 inhibitor rescued the downregulation of CDC25A expression in the MMS-induced S-phase-arrested HeLa cells (Figure 3(a) and (b) ). These results suggest that miR-16 directly regulate CDC25A expression, which is supported by a previous luciferase activity experiment with a RLuc-CDC25A-3′UTR fragment [9] . However, recovered CDC25A expression in the presence of the miR-16 inhibitor did not release the MMS-induced inhibitory effects of S-phase progression (data not shown), implying that rescue of CDC25A downregulation by miR-16 alone might not be sufficient for recovery of MMS-induced S-phase-arrested HeLa cells. These results indicate that specific upregulation of miR-16 expression in MMS-treated S-phase-arrested HeLa cells could functionally downregulate targets such as CDC25A. and has been widely used for synchronizing cells at the G 1 /S point, but it also induces DNA strand breaks in mammalian cells [10] . Our previous work showed that longer exposure to HU resulted in higher levels of DNA damage in CHO cells, as well as S-phase arrest [11] . In the present study, S-phase HeLa cells were treated with indicated concentrations of HU for 4 h, respectively. The HU treatments resulted in arrest of HeLa cells at the S-phase (Figure 4(a) ). However, real-time PCR analysis did not detect significant upregulation of miR-16 expression in HU-induced S-phasearrested cells (Figure 4(b) ). Furthermore, Western blot analysis revealed similar protein levels of CDC25A between untreated S-phase HeLa cells and HU-treated S-phase cells (Figure 4(c) ). In conclusion, these results showed that MMS treatment resulted in upregulation of miR-16 expression, but HU treatment did not induce this effect, although both drug-treatments resulted in S-phase arrest of HeLa cells.
miR-16 expression is not upregulated in HU-induced S-phase-arrested HeLa cells
Hydroxyurea (HU) is an inhibitor of ribonucleotide reducetase
It is widely recognized that different kinds of DNA damage during S-phase result in differential activation of various signaling pathways in the DNA damage checkpoint [12] [13] [14] . As a widely-used DNA damaging alkylating agent, MMS adds methyl groups to DNA at 7-guanine or 3-adenine, thereby inducing structural damage or DNA single-stranded breaks [15] , which often activate the base excision repair pathway [16] . In contrast, HU treatment causes DNA double-stranded breaks in mammalian cells, as well replication disturbances [10] [11] [12] , which induces activation of the ATM/Chk2 pathway [17, 18] . It has been reported that MMS activates the p21-dependent S-phase DNA damage checkpoint, but suppresses the CDC25A-dependent checkpoint, whereas UV irradiation results in entirely opposite cellular responses within the same cells [19] . Based on these observations, it is possible that upregulation of miR-16 expression relies on a particular cellular context determined by MMS-induced responses in terms of the S-phase checkpoint selection, whereas no such cellular context is generated under by HU treatment.
In conclusion, the present study demonstrates that expression levels of miRNAs in mammalian cells are delicately regulated under variable cellular contexts, which are determined by particular stages of the cell cycle and/or by different environmental stresses.
